Back to library
Metabolic

SLU-PP-332

SLU-PP-332 is a REV-ERB α/β agonist that upregulates mitochondrial biogenesis, fatty-acid oxidation, and skeletal-muscle oxidative capacity — pharmacologically mimicking the effects of endurance exercise. Research profile: fat loss and cardiovascular / metabolic endurance when physical cardio is restricted (injury, mobility limitation, time constraint).

10 mg vialHalf-life: ~6-8 hours (research estimate)1x dailyStandard · ≤10 mg/mL
Order: Coming soon

Overview

Clinical Benefits
  • Exercise-mimetic metabolic activation
  • Fat oxidation
  • Endurance / stamina
  • Mitochondrial biogenesis
Administration

Subcutaneous injection

Drug class: rev erb agonist

Clinical Dosing

Typical dosage
0.5-1mg daily
Starting dose
0.5mg
Cadence
1x daily
Full titration schedule
PhaseDose
Weeks 1-20.5mg once daily
Weeks 3-41mg once daily
Weeks 5-81mg once daily — cycle 8 weeks on / 4 weeks off

Safety Profile

Side effects
  • • Insomnia if dosed late (REV-ERB is circadian)
  • • Appetite shift
Contraindications
  • • Pregnancy
  • • Active cancer

Featured in these stacks

Frequently asked questions

SLU-PP-332 is most commonly researched for: Exercise-mimetic metabolic activation, Fat oxidation, Endurance / stamina, Mitochondrial biogenesis.

Ready to build a protocol with SLU-PP-332?

LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.

You’ll be asked to sign in first. Free tier includes the chat preview.

Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.

Add to Home Screen

Install PeptideAI for quick access and an app-like experience.